Pharmacotherapy: How much drug is there?

Ocular Surface

Volumn 5, Issue 1, 2007, Pages 58-61

  Novack, Gary D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; BSS PLUS; CORTICOSTEROID; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ARTICLE; CLINICAL TRIAL; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EYE DISEASE; EYE INFLAMMATION; HUMAN; OFF LABEL DRUG USE; PHARMACODYNAMICS; RETINA VEIN OCCLUSION; RISK BENEFIT ANALYSIS; VITRECTOMY; DRUG ADMINISTRATION ROUTE; METABOLISM; REVIEW; TREATMENT OUTCOME;

DRUG ADMINISTRATION ROUTES; EYE DISEASES; GLUCOCORTICOIDS; HUMANS; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE;

EID: 34447104655     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1542-0124(12)70054-x     Document Type: Article

References (8)

1. Kaufman B, Novack GD. Compliance issues in manufacturing of drugs. Ocul Surf 2003;1:80-5
2. Novack GD. Pipeline: Thoughts generated by the Annual Meeting of the American Society of Clinical Pharmacology and Therapeutics. Ocul Surf 2004;2:212-4
3. Novack GD. Pipeline: Risks and benefits. Ocul Surf 2006;4:58-60
4. Garcia-Arumi J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 2005;89:1112-4
5. Spandau UH, Derse M, Schmitz-Valckenberg P, et al. Triamcinolone acetonide concentration after filtration of the solvent agent. Am J Ophthalmol 2005;139:712-3
6. Ober MD, Barile GR, Tari SR, et al. Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection. Am J Ophthalmol 2006;142:597-600
7. Thomas ER, Wang J, Ege E, et al. Intravitreal triamcinolone acetonide concentration after subtenon injection. Am J Ophthalmol 2006;142:860-1
8. Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006;26:339-44